Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 1958 entries
View as:

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Phase: N/A Priority: Normal
NCT ID: NCT01109316 Org: User:
Start: 04/30/10 End: 08/31/11 Due: 08/31/12

A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00191984 Org: User:
Start: 06/30/04 End: 05/31/08 Due: 05/31/09

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00191555 Org: User:
Start: 08/31/03 End: 05/31/06 Due: 05/31/07

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT03730662 Org: User:
Start: 11/20/18 End: 04/22/21 Due: 04/22/22

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT03341312 Org: User:
Start: 11/13/17 End: 03/31/18 Due: 03/31/19

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

Phase: N/A Priority: Normal
NCT ID: NCT00311532 Org: User:
Start: 03/31/06 End: 05/31/07 Due: 05/31/08

A Study of LY3374849 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03726125 Org: User:
Start: 11/20/18 End: 09/27/19 Due: 09/27/20

A Study of Lasmiditan and Propranolol in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03270644 Org: User:
Start: 08/31/17 End: 11/22/17 Due: 11/22/18

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Phase: N/A Priority: Normal
NCT ID: NCT00191906 Org: User:
Start: 04/30/05 End: 12/31/07 Due: 12/31/08

A Study of LY3202626 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03023826 Org: User:
Start: 01/15/17 End: 04/04/17 Due: 04/04/18

A Study in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01253265 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

A Drug Interaction Study of LY3871801 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05602675 Org: User:
Start: 11/02/22 End: 03/29/23 Due: 03/29/24

Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00191165 Org: User:
Start: 03/31/04 End: 04/30/08 Due: 04/30/09

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05536804 Org: User:
Start: 02/08/23 End: 10/31/26 Due: 10/31/27

A Study of Imlunestrant (LY3484356) in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT05509816 Org: User:
Start: 09/12/22 End: 11/30/22 Due: 11/30/23

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03861039 Org: User:
Start: 03/30/19 End: 02/16/21 Due: 02/16/22

A Study in People With High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00133380 Org: User:
Start: 07/31/05 End: 09/30/06 Due: 09/30/07

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00363766 Org: User:
Start: 09/30/06 End: 10/31/08 Due: 10/31/09

A Multiple Dose Study of LY3502970 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05051566 Org: User:
Start: 09/16/21 End: 04/04/22 Due: 04/04/23

A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

Phase: N/A Priority: Normal
NCT ID: NCT01020786 Org: User:
Start: 11/30/09 End: 06/30/12 Due: 06/30/13

A Study of LY2127399 in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01576549 Org: User:
Start: 05/31/12 End: 05/31/13 Due: 05/31/14

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06937411 Org: User:
Start: 02/13/23 End: 10/30/23 Due: 10/30/24

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)

Phase: N/A Priority: Normal
NCT ID: NCT01794000 Org: User:
Start: 04/30/13 End: 12/31/15 Due: 12/31/16

A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT02197520 Org: User:
Start: 07/31/14 End: 06/30/15 Due: 06/30/16

A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03338010 Org: User:
Start: 03/22/18 End: 03/18/20 Due: 03/18/21